Avella Specialty Pharmacy began as a single pharmacy in Scottsdale, Arizona in 1996. It has since expanded to become one of the fastest-growing healthcare companies in the nation, with locations in eight states and a national distribution center. Through it all, Avella has stayed true to our steadfast vision: facilitating a hands-on, patient and physician focused approach to the dynamic and growing arena of specialty pharmaceuticals.
The Accreditation Commission for Health Care (ACHC) recognizes Avella for complying with national standards that facilitate a higher level of performance and quality across all of its clinical and operational processes.
As a designated outsourcing facility, Avella consents to greater federal oversight and adherence to current good manufacturing practices – further demonstrating our commitment to providing the highest level of care and quality for our patients.
Zydelig (idelalisib) is a breakthrough medication used to treat three types of blood cancer. As one of a limited number of specialty pharmacies with access to this oncology medication, Avella’s clinical team is proud to offer such an innovative therapy.
Avella creates a mobile app and online tool to help patients conveniently manage their prescriptions. The mobile app is one of the first of its kind in the specialty pharmacy industry. Both platforms allow patients to securely request prescription refills, view prescription history and transfer prescriptions, in addition to offering refill reminders and important information about medications.
Imbruvica (ibrutinib) was initially only indicated to treat patients with mantle cell lymphoma (MCL), but was later FDA approved for patients with chronic lymphocytic leukemia (CLL) as well. Avella is one of only five specialty pharmacies authorized to dispense Imbruvica, and is fully prepared to meet an increase in demand for the medication.
Rebecca Shanahan’s two decades of successful leadership in the healthcare sector, as well as five years of service on Avella’s Board of Directors, make her an excellent choice to succeed founder John Musil, Pharm.D., as CEO of Avella. Her goals as she entered this position were to expand Avella’s clinical pharmacy, patient advocacy, and specialty pharmacy services into new disease categories and via new healthcare partnerships – all areas of success within her first year as CEO.
Avella continues to be recognized as of the nation’s fastest-growing companies thanks to a three-year sales growth of 379%. Avella is also identified as #86 on the list of top 100 health companies in the country.
URAC, a Washington, D.C.-based health care accrediting organization that establishes proven standards for the health care industry, recognizes Avella’s dedication to quality, service and patient safety.
Genentech, manufacturer of Tarceva, shifted distribution of the drug to a limited network of select specialty pharmacies to provide appropriate support and guidance for patients receiving this oncology medication. Avella is honored to be chosen as one of these select specialty pharmacies.
The first issue of Dispensing Excellence is distributed by Avella to physicians, nurses, medical assistants and patients nationwide to encourage the sharing of knowledge and expertise about specialty medications and the conditions they treat.
Avella began its journey as a compounding pharmacy called “The Apothecary Shops,” but changes its name to reflect the company’s pioneering spirit in the specialty pharmacy industry, as well as to define the transformation the company has made over the previous 16 years.
Inc. Magazine ranks Avella as one of the fastest-growing companies in the nation for the sixth straight year with a three-year growth of 298%. Arizona Corporate Excellence (ACE) Awards recognizes Avella as the fastest-growing privately held company based in Arizona. This sustained growth allows Avella to offer expanded clinical services to customers.
Avella’s wholesale division achieves this prestigious accreditation that validates the close attention to detail in all of our processes.
Primarily focused on infectious diseases, Colorado Pharmacy offers new and exciting customer expanded clinical services under the Avella brand. To complement existing national distribution capabilities, Avella opens in Orlando, FL with future expansion at this location in mind.
Receiving distribution rights for Eylea, an injectable medication that prevents blindness by treating age-related macular degeneration, continues to verify Avella as a market leader in compounded drugs for ophthalmology.
With a prime retail location and capacity for distribution, this location serves patients across the states of Texas, Louisiana, Arkansas and Oklahoma.
The Arizona Corporate Excellence Awards, presented by The Business Journal, honor founder and then-CEO John Musil, Pharm. D., for leading one of Arizona’s largest and fastest-growing private companies. The award recognizes Musil’s innovative approaches, community involvement, dedication to company employees and leadership accomplishments, all of which have been crucial to The Apothecary Shops’ success since its earliest beginnings.
The acquisition of Greater Sacramento Pharmacy facilitates expanding services for patients and offers The Apothecary Shops additional clinical expertise in the key focus area of oncology.
Nexavar was the first oral-cancer therapy that inhibited both tumor and tumor blood vessel growth among patients with advanced kidney and liver cancers. The Apothecary Shops becomes one of only 15 companies nationwide qualified to distribute the drug.
Opening a new corporate headquarters and expanding our call center and national distribution facility to over 25,000-square-feet allows The Apothecary Shops to keep up with the growing base of patients around the nation.
The addition of Afinitor, Nexavar and Caphosol to The Apothecary Shops’ inventory of oncology pharmaceuticals reflects the company’s growing influence in the specialty pharmacy niche.
With a focus in clinical excellence and quality, The Apothecary Shops achieve recognition and accreditation as leaders in the practice of compounding patient medication.
Opening our first location outside of the Southwest establishes our presence as a national pharmacy.
The Apothecary Shops expands its operations outside of Arizona to open a location in Las Vegas, Nevada.
The Apothecary Shops opens a new location in Tucson, Arizona. This is the first time The Apothecary Shops expands outside of the greater Phoenix area.
The Apothecary Shops expands to six community-based pharmacies in metropolitan Phoenix in response to increased demand for its services. These new pharmacies are developed in strategic locations near clinical practices.
Avella Specialty Pharmacy opens its first pharmacy in Scottsdale, Ariz., under former company name (The Apothecary Shops) to address the community’s growing need for expert clinical support and guidance along with breakthrough medications.